We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

What guides us

Geistlich stands for the values of “Regeneration Expert”, “Scientific”, “Family”, “Connected” and “Pioneer” and embodies these in its day-to-day work.

Geistlich’s passion for regeneration allows it to develop pioneering medical devices for restoring bone, cartilage and soft tissue. The company’s regenerative approach is the counterpart to repair – replacing tissue defects with, for example, artificial joints.

 

 

Scientific and well-founded

Geistlich uses a substantial part of its budget for its own research and development. The entire value-added chain is under Geistlich’s control at its site in central Switzerland. The company places the greatest value on high quality products with scientifically proven safety and efficacy. Geistlich biomaterials are documented in over 1,400 scientific publications that demonstrate their efficacy. Numerous internal and external audits ensure the high quality standards.

“Our products support the body’s regeneration from within.”
Dr. Mark Spilker, CSO Geistlich Pharma AG

 

Geistlich’s vision for 2030

Geistlich’s goal for 2030 is to continue strengthening its market leadership in regenerative dentistry and further develop the Geistlich Surgery and Geistlich Medical business units. To achieve this, the company is planning new regenerative products as well as new application areas and techniques for its established products. The vision that drives us is “The Regeneration Company.”


Dr. Mirjam Kessler
Director Corporate Communications